Cite

HARVARD Citation

    He, X. et al. (2016). Optimal tumor shrinkage predicts long-term outcome in advanced nonsmall cell lung cancer (NSCLC) treated with target therapy. Medicine. 95 (31), p. . [Online]. 
  
Back to record